Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch to Dovato in Biktarvy-suppressed HIV
NCT04826562Phase 4Unknown
- Sponsor
- Saint Michael's Medical Center
- Start
- Sep 2021
- Primary completion
- Oct 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of dolutegravir + lamivudine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Saint Michael's Medical Center. Status: unknown.
02
Drugs
dolutegravir + lamivudine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT04826562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04826562.